Alnuctamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameAlnuctamab Biosimilar - Anti-TNFRSF17;CD3E mAb - Research Grade
SourceCAS 2296827-07-9
SpeciesHumanized
Expression systemXtenCHO
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°)
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Delivery Time3-5 days if in stock; 3 week if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsAlnuctamab,ALNUCTAMAB,TNFRSF17;CD3E,anti-TNFRSF17;CD3E
ReferencePX-TA1642
NoteFor research use only. Not suitable for human use.
IsotypeBispecific ,IgG1;IgG1,Kappa;Lambda
ClonalityMonoclonal Antibody

Publication

Hellberg, Ella, Development of immunoassays that can assess therapeutic bispecific antibodies on the Gyrolab platform, 2023, Independent thesis Advanced level,urn:nbn:se:uu:diva-507186

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Alnuctamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD269 / TNFRSF17, C-Fc, recombinant protein
Antigen

CD269 / TNFRSF17, C-Fc, recombinant protein

PX-P5605 385€
Stable Isotope Labelled Alnuctamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade
SIL

Stable Isotope Labelled Alnuctamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade

PX-TA1642-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products